Abstract
The FAMMM syndrome consists of the familial occurrence of cutaneous malignant melanoma and atypical nevi (dysplastic nevi), and is inherited as an autosomal dominant trait. Conflicting results have been reported on the question of whether the syndrome includes increased susceptibility to non-melanoma cancers. We have studied cancer of all anatomic sites and histologies in nine FAMMM families which were ascertained in a pigmented lesions clinic in the Netherlands. We evaluated two hypotheses: that the number of systemic cancers observed in the families was excessive, compared to expected incidence, based on Dutch incidence data, and that there was variation (or heterogeneity) among families in the frequency of systemic cancer. A significant excess of systemic cancer (especially digestive tract cancer) was observed. Significant heterogeneity was also found among the families; three of the nine families had marked excess in numbers of systemic cancers, and the remaining families had normal numbers of cancers among the known FAMMM gene carriers and their first degree relatives. Thus, we provide evidence of increased susceptibility to systemic cancer occurring in conjunction with the FAMMM syndrome in a subset of this resource.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergman, W., Watson, P., de Jong, J. et al. Systemic cancer and the FAMMM syndrome. Br J Cancer 61, 932–936 (1990). https://doi.org/10.1038/bjc.1990.209
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.209
This article is cited by
-
Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): What’s worse?
Wiener Medizinische Wochenschrift (2014)
-
Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals
Journal of Gastroenterology (2011)
-
Risk factors for pancreatic adenocarcinoma: Are we ready for screening and surveillance?
Current Gastroenterology Reports (2005)
-
Familial pancreatic carcinoma in Jews
Familial Cancer (2004)